This groundbreaking conference discusses the future of therapeutic agents delivered directly to the brain and spinal cord. The development of medications and the devices to deliver them to the neurologic target, represents a very promising opportunity to treat difficult neurological conditions including pain, spasticity, epilepsy, Parkinson’s disease, Alzeheimer’s disease and Neuro-Oncology. The Targeted Drug Delivery Conference has gained a reputation for bringing together the top clinicians, scientists, and industry leaders to discuss the future of this promising treatment avenue.
This year a CME-course, to discuss the present clinical applications of intrathecal infusion, will be held on Friday. Our goal is to improve patient outcomes associated with current uses of intrathecal drug delivery and discuss, from the clinical perspective, the translation of direct drug delivery into effective treatment options for currently refractory neurologic conditions.